Title:
ANTI-CORONAVIRUS AGENT
Document Type and Number:
WIPO Patent Application WO/2005/037296
Kind Code:
A1
Abstract:
An antiviral agent that is effective in treating coronavirus and can be formed into various products whose efficacy durability is promising. In particular, an antiviral agent being effective in treating coronavirus, comprising a silver ion carrier; a product capable of inactivating coronavirus, comprising the same; and a method of inactivating coronavirus. The silver ion carrier is at least one member selected from among potassium titanate, potassium uranate, potassium vanadate, potassium niobate, sodium tungstate, magnesium molybdate, potassium pentaborate, aluminosilicate, aluminum phosphate, nickel hexacyanoferrate, sepiolite, montmorillonite, silica gel, zeolite, β-alumina, titanium oxide hydrate, hydroxyapatite and glass carriers, represented by the formula (1): AgaAbM2c(PO4)d·nH2O (1).
Inventors:
SUGIURA KOJI (JP)
ONO YASUHARU (JP)
ONO YASUHARU (JP)
Application Number:
PCT/JP2003/014008
Publication Date:
April 28, 2005
Filing Date:
October 31, 2003
Export Citation:
Assignee:
TOAGOSEI CO LTD (JP)
SUGIURA KOJI (JP)
ONO YASUHARU (JP)
SUGIURA KOJI (JP)
ONO YASUHARU (JP)
International Classes:
A61K9/00; A61K33/38; A61K47/02; A61K47/26; (IPC1-7): A61K33/38; A61P31/12
Foreign References:
| JPH06263916A | 1994-09-20 | |||
| JPH05105609A | 1993-04-27 |
Other References:
RENTZ DO COMM CNMO E. J.: "Viral pathogens and severe acute respiratory syndrome: oligodynamic Ag+ for direct immune intervention", JOURNAL OF NUTRITIONAL & ENVIRONMENTAL MEDICINE, vol. 13, no. 2, 2003, pages 109 - 118, XP009022135
See also references of EP 1676582A4
See also references of EP 1676582A4
Download PDF: